Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 25/03/20191 min de lecture
Development of Antibacterial Drugs for the Treatment of Nontuberculous Mycobacterial Disease; Public Workshop; Request for Comments
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Development of Antibacterial Drugs for the Treatment of Nontuberculous Mycobacterial Disease." The purpose of the public workshop is to discuss the clinical trial design considerations, including endpoints, related to the development of antibacterial drug products for treatment of nontuberculous mycobacterial (NTM) disease.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →